![Patrice Debre](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrice Debre
Direttore/Membro del Consiglio presso European & Developing Countries Clinical Trials Partnership
Profilo
Patrice Debre is the founder of Minka Therapeutics SA. He is currently the Vice Chairman at European & Developing Countries Clinical Trials Partnership.
Previously, he worked as the Director-Cellular Immunology Research Unit at Groupe hospitalier Pitié-Salpêtrière from 1998 to 2010 and as a Professor at Université Pierre et Marie Curie.
Posizioni attive di Patrice Debre
Società | Posizione | Inizio |
---|---|---|
European & Developing Countries Clinical Trials Partnership | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Patrice Debre
Società | Posizione | Fine |
---|---|---|
Groupe hospitalier Pitié-Salpêtrière
![]() Groupe hospitalier Pitié-Salpêtrière Hospital/Nursing ManagementHealth Services Groupe hospitalier Pitié-Salpêtrière is a part of the AP-HP, which is the CHU of Ile-de-France and is based in Paris, France. The AP-HP has 38 hospitals that receive 8.3 million patients every year. The French company provides medical, social, and legal support to victims of violence through its Maison des Femmes program. The private company also has several research chairs in different fields and all of its clinical services are subject to regulatory certification by the Haute Autorité de Santé (HAS). The company uses indicators to regularly evaluate the quality and safety of the care it provides. The company also has a team of social workers who can help patients with their needs outside of the hospital. The company has protocols for cooperation between healthcare professionals to extend the scope of activities of paramedics while ensuring the quality and safety of care. | Corporate Officer/Principal | 01/01/2010 |
Minka Therapeutics SA
![]() Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Fondatore | - |
Université Pierre et Marie Curie | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Université Pierre et Marie Curie | Consumer Services |
European & Developing Countries Clinical Trials Partnership | |
Groupe hospitalier Pitié-Salpêtrière
![]() Groupe hospitalier Pitié-Salpêtrière Hospital/Nursing ManagementHealth Services Groupe hospitalier Pitié-Salpêtrière is a part of the AP-HP, which is the CHU of Ile-de-France and is based in Paris, France. The AP-HP has 38 hospitals that receive 8.3 million patients every year. The French company provides medical, social, and legal support to victims of violence through its Maison des Femmes program. The private company also has several research chairs in different fields and all of its clinical services are subject to regulatory certification by the Haute Autorité de Santé (HAS). The company uses indicators to regularly evaluate the quality and safety of the care it provides. The company also has a team of social workers who can help patients with their needs outside of the hospital. The company has protocols for cooperation between healthcare professionals to extend the scope of activities of paramedics while ensuring the quality and safety of care. | Health Services |
Minka Therapeutics SA
![]() Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Health Technology |
- Borsa valori
- Insiders
- Patrice Debre